Businesses marketing unproven stem cell interventions proliferate within the U.S. and in the larger global marketplace. There have been global efforts by scientists, patient advocacy groups, bioethicists, and public policy experts to counteract the uncontrolled and premature commercialization of stem cell interventions. In this commentary, we posit that medical societies and associations of health care professionals have a particular responsibility to be an active partner in such efforts. We review the role medical societies can and should play in this area through patient advocacy and awareness initiatives.
Keywords: health care professionals; medical societies; patients; unproven stem cell interventions; “stem cell” clinics.
Copyright © 2017 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.